This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1996-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Berlin, DE (1996)
- Glienicke, DE (2002)
Company Filing History:
Years Active: 1996-2002
Title: Innovations of Alessandro Lobbia
Introduction
Alessandro Lobbia is a notable inventor based in Glienicke, Germany. He has made significant contributions to the field of contraception through his innovative research and development. With a total of two patents to his name, Lobbia's work is recognized for its potential impact on reproductive health.
Latest Patents
Lobbia's latest patents include groundbreaking inventions related to zona pellucida proteins for contraception. This invention focuses on the use of peptides derived from zona pellucida proteins, which are utilized for contraceptive purposes. The pharmaceutical formulations developed from these peptides are designed to be effective without causing an immunogenic effect. Another significant patent involves peptide compounds, particularly LHRH-antagonists, which further showcases his expertise in this area.
Career Highlights
Alessandro Lobbia is currently associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals. His work at this organization has allowed him to explore innovative solutions in reproductive health, contributing to the development of effective contraceptive methods.
Collaborations
Lobbia has collaborated with esteemed colleagues such as Paul Thamm and Thomas Brumby. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Alessandro Lobbia's contributions to the field of contraception through his innovative patents highlight his role as a significant inventor. His work continues to influence advancements in reproductive health, showcasing the importance of innovation in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile